These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32384313)

  • 41. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).
    Alaghband-Rad J; Hakimshooshtary M
    Eur Child Adolesc Psychiatry; 2009 Mar; 18(3):131-5. PubMed ID: 19190958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obsessive-compulsive spectrum disorders: effective treatment with paroxetine.
    Ravindran AV; Lapierre YD; Anisman H
    Can J Psychiatry; 1999 Oct; 44(8):805-7. PubMed ID: 10566112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder.
    Coskun M; Zoroglu S
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):297-300. PubMed ID: 19519265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SSRI-induced mania in obsessive-compulsive disorder.
    Diler RS; Avci A
    J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):6-7. PubMed ID: 9893408
    [No Abstract]   [Full Text] [Related]  

  • 45. Oral contraceptive pill use and changes in obsessive-compulsive symptoms.
    Labad J; Menchón JM; Alonso P; Segalàs C; Jiménez S; Vallejo J
    J Psychosom Res; 2006 Jun; 60(6):647-8. PubMed ID: 16731243
    [No Abstract]   [Full Text] [Related]  

  • 46. Sertraline-Induced Amotivationel Syndrome in a 12-Year-Old Girl: A Case Report.
    Yildiz Bayindir B; Karayagmurlu A
    Clin Neuropharmacol; 2021 Jul-Aug 01; 44(4):154-155. PubMed ID: 33871427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolonged neonatal complications after in utero exposure to fluoxetine.
    Alehan F; Saygi S; Tarcan A; Gürakan B
    J Matern Fetal Neonatal Med; 2008 Dec; 21(12):921-3. PubMed ID: 18985556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potentiation of fluoxetine by aminoglutethimide, an adrenal steroid suppressant, in obsessive-compulsive disorder resistant to SSRIs: a case report.
    Chouinard G; Bélanger MC; Beauclair L; Sultan S; Murphy BE
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Aug; 20(6):1067-79. PubMed ID: 8888111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidepressant medications in children.
    Vitiello B; Swedo S
    N Engl J Med; 2004 Apr; 350(15):1489-91. PubMed ID: 15071123
    [No Abstract]   [Full Text] [Related]  

  • 50. A review of pharmacologic treatments for obsessive-compulsive disorder.
    Kaplan A; Hollander E
    Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.
    Koponen H; Lepola U; Leinonen E; Jokinen R; Penttinen J; Turtonen J
    Acta Psychiatr Scand; 1997 Nov; 96(5):343-6. PubMed ID: 9395151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotonin syndrome precipitated by sertraline and discontinuation of clozapine.
    Srisuma S; Hoyte CO; Wongvisavakorn S; Wanaukul W
    Clin Toxicol (Phila); 2015; 53(8):840-1. PubMed ID: 26161840
    [No Abstract]   [Full Text] [Related]  

  • 54. The use of fluoxetine in Gilles de la Tourette syndrome and obsessive compulsive behaviours: preliminary clinical experience.
    Eapen V; Trimble MR; Robertson MM
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):737-43. PubMed ID: 8843495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine.
    Kampman M; Keijsers GP; Hoogduin CA; Verbraak MJ
    Acta Psychiatr Scand; 2002 Oct; 106(4):314-9. PubMed ID: 12225499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obsessive-compulsive symptoms with risperidone.
    Mahendran R
    J Clin Psychiatry; 1999 Apr; 60(4):261-3. PubMed ID: 10221290
    [No Abstract]   [Full Text] [Related]  

  • 57. Fluoxetine versus phenelzine in obsessive-compulsive disorder.
    Golwyn DH; Sevlie CP
    Am J Psychiatry; 1999 Jan; 156(1):159-60. PubMed ID: 9892321
    [No Abstract]   [Full Text] [Related]  

  • 58. Association of Electroencephalographic Alpha-2 Activity With Fluoxetine Response in Obsessive-Compulsive Disorder.
    Arıkan MK; Günver MG; İlhan R
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):207-209. PubMed ID: 33464030
    [No Abstract]   [Full Text] [Related]  

  • 59. Quetiapine treatment in a patient with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania.
    Matur Z; Uçok A
    Isr J Psychiatry Relat Sci; 2003; 40(2):150-2. PubMed ID: 14509206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preschool children with obsessive-compulsive disorder and fluoxetine treatment.
    Ercan ES; Kandulu R; Akyol Ardic U
    Eur Child Adolesc Psychiatry; 2012 Mar; 21(3):169-72. PubMed ID: 22271063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.